MONEY

Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 23, 2024 - 16:00
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects
Read More

Tags:

Previous Article

Morgan Stanley bullish on Structure Therapeutics stock ahead of key obesity trial

Next Article

BofA sees earnings risk for Zegna stock amid weaker global luxury demand

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Analysis-Australia could be canola trade winner if China gets over fungus worries

Analysis-Australia could be canola trade winner if Chin...

Tomas Kauer - Mode... Oct 1, 2024

Costco stock soars to all-time high of $918.98 amid robust growth

Costco stock soars to all-time high of $918.98 amid rob...

Tomas Kauer - Mode... Sep 14, 2024

Israeli airstrikes kill 11 Palestinians in Gaza

Israeli airstrikes kill 11 Palestinians in Gaza

Tomas Kauer - Mode... Sep 29, 2024